Regina Castro from the Mayo Clinic said, "the GLP-1 class of drugs isnt recommended if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia
Other GLP-1 Medications Although Ozempic (semaglutide) is a member of the GLP-1 class, its formulation distinguishes it from other medications such as Mounjaro (tripeptidea dual GLP-1 and GIP agonist) and Wegovy (also semaglutide, but at a larger dose) by enabling: Once-weekly dosing Sustained effects on appetite Strong glucose control This makes it suitable for long-term chronic management
For example, viral infections may dramatically increase the mortality rate in mammalian populations (e.g., border disease virus 6
Its very common for your top or bottom lip to be fuller than the other, darlings
It is a dual GIP and GLP-1 receptor agonist, meaning it activates two incretin pathways simultaneously
Dietary habits may be counteracting the appetite reduction